Alchemab awarded 1.7 million grant to develop Huntington’s disease therapy
Alchemab Therapeutics - 16-Dec-2022New antibody approach aims to slow or halt Huntington’s disease progression
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Government funded, not-for-profit organisation
Medicines Discovery Catapult is a national Life Sciences service that reshapes drug discovery to deliver better treatments for patients
We partner with innovators across the sector, helping them turn bold scientific ideas into real-world impact.
Our model supports drug discovery companies at every step, from early research through to commercialisation, by providing access to world-class science, laboratories, technologies, and expertise.
We de-risk drug discovery, run collaborative R&D partnerships, and reinvest in our sector to drive growth.
Visit website: https://md.catapult.org.uk/
Details last updated 19-Dec-2020
New antibody approach aims to slow or halt Huntington’s disease progression
Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer